Harbour BioMed Announces Dosing of First Patient of Next-Generation Anti-CTLA-4 Antibody in Combination with PD-1 Antibody in Patients with NSCLC

Stock Information for MMTec Inc.

Loading

Please wait while we load your information from QuoteMedia.